Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Cash & Current Investments (2016 - 2025)

Corcept Therapeutics (CORT) has disclosed Cash & Current Investments for 15 consecutive years, with $372.2 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments fell 2.92% to $372.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $372.2 million through Dec 2025, down 2.92% year-over-year, with the annual reading at $372.2 million for FY2025, 2.92% down from the prior year.
  • Cash & Current Investments hit $372.2 million in Q4 2025 for Corcept Therapeutics, down from $421.7 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $473.2 million in Q2 2024 to a low of $223.5 million in Q4 2021.
  • Historically, Cash & Current Investments has averaged $376.5 million across 5 years, with a median of $371.1 million in 2022.
  • Biggest five-year swings in Cash & Current Investments: plummeted 49.28% in 2021 and later skyrocketed 93.11% in 2022.
  • Year by year, Cash & Current Investments stood at $223.5 million in 2021, then surged by 93.11% to $431.7 million in 2022, then dropped by 14.7% to $368.2 million in 2023, then grew by 4.1% to $383.3 million in 2024, then decreased by 2.92% to $372.2 million in 2025.
  • Business Quant data shows Cash & Current Investments for CORT at $372.2 million in Q4 2025, $421.7 million in Q3 2025, and $342.2 million in Q2 2025.